跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Risperdal Consta
Approved
STANDARD
Risperdal Consta
Alkemes Conrolled Therspeutics II
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
63fed4045a922b20
Company
Alkemes Conrolled Therspeutics II
Type
Standard
Approval Details
Approval Id
63fed4045a922b20
Drug Approval Philippines Name
Risperdal Consta
Product Name
Risperdal Consta
Registration Number
DR-XY28755
Brand Name
Risperdal Consta
Generic Name
Risperidone
Dosage Form
Prolonged-Release Powder For Suspension For Injection (Im)
Dosage Strength
25 mg
Manufacturer
Alkemes Conrolled Therspeutics II
Importer
Johnson & Johnson (Philippines), Inc.
Distributor
ZUELLIG PHARMA CORPORATION
Issuance Date
25 July 2023
Expiry Date
07 July 2028
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
63fed4045a922b20
Type
Standard
Back to Philippines FDA Approvals
Risperdal Consta - Philippines FDA Drug Approval Details